

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.52370230 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.52370230 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.80128368 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.66822354 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.66239484 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.66239484 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.85908388 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.80377973 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.47844600 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.23921361 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14463732 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 4.09606787 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96652774 |
| 14 | response to interleukin-15 (GO:0070672) | 3.95719539 |
| 15 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.94986331 |
| 16 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.89096289 |
| 17 | ribosomal small subunit assembly (GO:0000028) | 3.85036117 |
| 18 | positive regulation of granulocyte differentiation (GO:0030854) | 3.80142371 |
| 19 | B cell receptor signaling pathway (GO:0050853) | 3.78562018 |
| 20 | negative regulation of neurotransmitter transport (GO:0051589) | 3.67512775 |
| 21 | negative T cell selection (GO:0043383) | 3.67214530 |
| 22 | regulation of B cell differentiation (GO:0045577) | 3.65914334 |
| 23 | mast cell activation (GO:0045576) | 3.65480239 |
| 24 | interferon-gamma production (GO:0032609) | 3.62221479 |
| 25 | nerve growth factor signaling pathway (GO:0038180) | 3.60811753 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 3.55526453 |
| 27 | definitive hemopoiesis (GO:0060216) | 3.50307841 |
| 28 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.49788462 |
| 29 | cell wall macromolecule catabolic process (GO:0016998) | 3.48637687 |
| 30 | negative thymic T cell selection (GO:0045060) | 3.44385744 |
| 31 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.42776252 |
| 32 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.42776252 |
| 33 | negative regulation of phagocytosis (GO:0050765) | 3.41725553 |
| 34 | positive regulation of vasculogenesis (GO:2001214) | 3.37325099 |
| 35 | defense response to protozoan (GO:0042832) | 3.34324176 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.34141712 |
| 37 | response to protozoan (GO:0001562) | 3.28050481 |
| 38 | regulation of platelet aggregation (GO:0090330) | 3.27227477 |
| 39 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.24950449 |
| 40 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.23869072 |
| 41 | relaxation of smooth muscle (GO:0044557) | 3.20629190 |
| 42 | T cell homeostasis (GO:0043029) | 3.20434143 |
| 43 | mast cell activation involved in immune response (GO:0002279) | 3.19208822 |
| 44 | mast cell degranulation (GO:0043303) | 3.19208822 |
| 45 | megakaryocyte development (GO:0035855) | 3.18206910 |
| 46 | cell wall macromolecule metabolic process (GO:0044036) | 3.12120474 |
| 47 | positive regulation of lamellipodium assembly (GO:0010592) | 3.10569372 |
| 48 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.10448657 |
| 49 | leukocyte aggregation (GO:0070486) | 3.09540525 |
| 50 | histamine secretion (GO:0001821) | 3.08507320 |
| 51 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04829403 |
| 52 | neutrophil mediated immunity (GO:0002446) | 3.01835541 |
| 53 | actin nucleation (GO:0045010) | 3.01068211 |
| 54 | positive regulation of interleukin-17 production (GO:0032740) | 2.99457818 |
| 55 | response to pheromone (GO:0019236) | 2.98728531 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98710726 |
| 57 | hepatocyte apoptotic process (GO:0097284) | 2.97369248 |
| 58 | necroptotic process (GO:0070266) | 2.96597218 |
| 59 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.94130905 |
| 60 | Rap protein signal transduction (GO:0032486) | 2.93060313 |
| 61 | signal peptide processing (GO:0006465) | 2.92263931 |
| 62 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.92130006 |
| 63 | myeloid cell development (GO:0061515) | 2.90599129 |
| 64 | neutrophil activation (GO:0042119) | 2.90359945 |
| 65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90203918 |
| 66 | regulation of response to interferon-gamma (GO:0060330) | 2.89843487 |
| 67 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.89042318 |
| 68 | regulation of germinal center formation (GO:0002634) | 2.86675824 |
| 69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.86641599 |
| 70 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.83426052 |
| 71 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83108315 |
| 72 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82581550 |
| 73 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.82188575 |
| 74 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.81568529 |
| 75 | natural killer cell mediated immunity (GO:0002228) | 2.80657160 |
| 76 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.80657160 |
| 77 | ncRNA 3-end processing (GO:0043628) | 2.80540529 |
| 78 | negative regulation of exocytosis (GO:0045920) | 2.77724564 |
| 79 | immunoglobulin mediated immune response (GO:0016064) | 2.77534805 |
| 80 | Peyers patch development (GO:0048541) | 2.76694141 |
| 81 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.76694141 |
| 82 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.75820810 |
| 83 | regulation of necroptotic process (GO:0060544) | 2.75762659 |
| 84 | regulation of interleukin-17 production (GO:0032660) | 2.75664192 |
| 85 | myeloid leukocyte mediated immunity (GO:0002444) | 2.75579062 |
| 86 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.75560174 |
| 87 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.75332636 |
| 88 | leukocyte degranulation (GO:0043299) | 2.73608424 |
| 89 | positive regulation of mast cell activation (GO:0033005) | 2.73317256 |
| 90 | lymphocyte homeostasis (GO:0002260) | 2.73241951 |
| 91 | lymph node development (GO:0048535) | 2.71510781 |
| 92 | regulation of memory T cell differentiation (GO:0043380) | 2.71395910 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.70834558 |
| 94 | T cell selection (GO:0045058) | 2.69553659 |
| 95 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.68483345 |
| 96 | purine-containing compound salvage (GO:0043101) | 2.67371038 |
| 97 | positive regulation of macrophage differentiation (GO:0045651) | 2.65612166 |
| 98 | regulation of mast cell activation (GO:0033003) | 2.64827005 |
| 99 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.64642634 |
| 100 | positive T cell selection (GO:0043368) | 2.64003760 |
| 101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64002531 |
| 102 | microglial cell activation (GO:0001774) | 2.63686661 |
| 103 | thrombin receptor signaling pathway (GO:0070493) | 2.63658494 |
| 104 | T cell receptor signaling pathway (GO:0050852) | 2.63377349 |
| 105 | response to type I interferon (GO:0034340) | 2.63290373 |
| 106 | mitochondrial DNA replication (GO:0006264) | 2.63182258 |
| 107 | COPI coating of Golgi vesicle (GO:0048205) | 2.63082786 |
| 108 | Golgi transport vesicle coating (GO:0048200) | 2.63082786 |
| 109 | regulation of mast cell degranulation (GO:0043304) | 2.62961318 |
| 110 | viral transcription (GO:0019083) | 2.61188471 |
| 111 | B cell mediated immunity (GO:0019724) | 2.60467350 |
| 112 | negative regulation of adaptive immune response (GO:0002820) | 2.60066034 |
| 113 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.60030643 |
| 114 | cotranslational protein targeting to membrane (GO:0006613) | 2.59430916 |
| 115 | positive regulation of lamellipodium organization (GO:1902745) | 2.59328984 |
| 116 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.59201946 |
| 117 | protein targeting to ER (GO:0045047) | 2.59112203 |
| 118 | sleep (GO:0030431) | 2.58948487 |
| 119 | T cell migration (GO:0072678) | 2.58737424 |
| 120 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.58693395 |
| 121 | protein localization to endoplasmic reticulum (GO:0070972) | 2.58340028 |
| 122 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58300106 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.58225225 |
| 124 | cellular response to type I interferon (GO:0071357) | 2.57504298 |
| 125 | type I interferon signaling pathway (GO:0060337) | 2.57504298 |
| 126 | regulation of alpha-beta T cell activation (GO:0046634) | 2.57103258 |
| 127 | positive thymic T cell selection (GO:0045059) | 2.57075194 |
| 128 | cellular response to zinc ion (GO:0071294) | 2.56378251 |
| 129 | granulocyte activation (GO:0036230) | 2.55797852 |
| 130 | DNA deamination (GO:0045006) | 2.55438855 |
| 131 | rRNA methylation (GO:0031167) | 2.55192956 |
| 132 | translational termination (GO:0006415) | 2.54251098 |
| 133 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.53603384 |
| 134 | response to peptidoglycan (GO:0032494) | 2.53459820 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.52574439 |
| 136 | leukocyte homeostasis (GO:0001776) | 2.52445261 |
| 137 | natural killer cell differentiation (GO:0001779) | 2.52354222 |
| 138 | negative regulation of B cell proliferation (GO:0030889) | 2.51195996 |
| 139 | ribonucleoprotein complex disassembly (GO:0032988) | 2.51117508 |
| 140 | T cell proliferation (GO:0042098) | 2.50870745 |
| 141 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.50647646 |
| 142 | neutrophil activation involved in immune response (GO:0002283) | 2.50587291 |
| 143 | tolerance induction (GO:0002507) | 2.50373004 |
| 144 | negative regulation of T cell mediated immunity (GO:0002710) | 2.50050408 |
| 145 | angiogenesis involved in wound healing (GO:0060055) | 2.49193785 |
| 146 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.49182211 |
| 147 | regulation of erythrocyte differentiation (GO:0045646) | 2.48972338 |
| 148 | detection of other organism (GO:0098543) | 2.48659764 |
| 149 | positive regulation of DNA recombination (GO:0045911) | 2.48638202 |
| 150 | thymic T cell selection (GO:0045061) | 2.47659644 |
| 151 | regulation of granulocyte differentiation (GO:0030852) | 2.46785112 |
| 152 | positive regulation of Rap GTPase activity (GO:0032854) | 2.46277399 |
| 153 | hemoglobin metabolic process (GO:0020027) | 2.46193656 |
| 154 | cellular extravasation (GO:0045123) | 2.46192597 |
| 155 | regulation of T-helper cell differentiation (GO:0045622) | 2.46117065 |
| 156 | response to interferon-beta (GO:0035456) | 2.45669851 |
| 157 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.44987496 |
| 158 | alpha-beta T cell activation (GO:0046631) | 2.43604044 |
| 159 | tRNA methylation (GO:0030488) | 2.43379574 |
| 160 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.43242369 |
| 161 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.43233820 |
| 162 | embryonic hemopoiesis (GO:0035162) | 2.42812870 |
| 163 | natural killer cell activation (GO:0030101) | 2.42435228 |
| 164 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41931258 |
| 165 | mature B cell differentiation (GO:0002335) | 2.41918845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.76206966 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77013229 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.46503675 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.45878769 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27352432 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.17385138 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.05778929 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03786479 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99904234 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.76202549 |
| 11 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.65937060 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.62153477 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61887270 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59941937 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56677848 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.47900760 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.44843620 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.39898296 |
| 19 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27622899 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26670657 |
| 21 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24977092 |
| 22 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.19885414 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.17147669 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14300777 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13522537 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10617048 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08826632 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.07355280 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06313885 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.05649199 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 2.03695765 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.02231163 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01747370 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99668361 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98863256 |
| 36 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93279976 |
| 37 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.92662777 |
| 38 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.89118806 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87997472 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87738160 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.87188813 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86399315 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86074862 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83248030 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.77060093 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.76890384 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.74826799 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74162714 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74027446 |
| 50 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73829902 |
| 51 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.69254672 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68595901 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68490597 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67778679 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67561166 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66351907 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64486659 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63612628 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.59907276 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59765901 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59485382 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.58886385 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57656089 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57225418 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56138868 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.53819086 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52754765 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.49536630 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.49356527 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49289407 |
| 71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.46671640 |
| 72 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45530501 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.43870833 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42533157 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40296246 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40253604 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40012647 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38883011 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36697267 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36600129 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.36503120 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.35862309 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34766192 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30369778 |
| 85 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28757207 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28374797 |
| 87 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.28108251 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.27739699 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26393705 |
| 90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.26331460 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 1.25065777 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24634033 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24419494 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22898699 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21208940 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19829102 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17656189 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17380960 |
| 99 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.17126414 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16751275 |
| 101 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.16332200 |
| 102 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.16089960 |
| 103 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16082557 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16065673 |
| 105 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.15978320 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15712939 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15620499 |
| 108 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15587606 |
| 109 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15328570 |
| 110 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15238520 |
| 111 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14308078 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14216668 |
| 113 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13559819 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13420528 |
| 115 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12723363 |
| 116 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12546474 |
| 117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11255756 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09800500 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09605464 |
| 120 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08838328 |
| 121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06688730 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06611305 |
| 123 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05753465 |
| 124 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05753465 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05556848 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04765622 |
| 127 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04423869 |
| 128 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03501404 |
| 129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03404233 |
| 130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03222331 |
| 131 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03021847 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02053961 |
| 133 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.01086440 |
| 134 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00089002 |
| 135 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99898950 |
| 136 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98766712 |
| 137 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98766712 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98558281 |
| 139 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97987250 |
| 140 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97690150 |
| 141 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97511656 |
| 142 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97127123 |
| 143 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.96162251 |
| 144 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96131066 |
| 145 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.96042991 |
| 146 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95962391 |
| 147 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95953803 |
| 148 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94924166 |
| 149 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94705022 |
| 150 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94337573 |
| 151 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.91950656 |
| 152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91269126 |
| 153 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90708551 |
| 154 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.88364991 |
| 155 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88231927 |
| 156 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86292867 |
| 157 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85513204 |
| 158 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85496277 |
| 159 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.84882470 |
| 160 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84655972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.43954694 |
| 2 | MP0002166_altered_tumor_susceptibility | 3.31416837 |
| 3 | MP0004510_myositis | 3.13564533 |
| 4 | MP0005671_abnormal_response_to | 3.09221138 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.91548120 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.82384612 |
| 7 | MP0000685_abnormal_immune_system | 2.73286626 |
| 8 | MP0002006_tumorigenesis | 2.59060929 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.58366488 |
| 10 | MP0008057_abnormal_DNA_replication | 2.51979520 |
| 11 | MP0001800_abnormal_humoral_immune | 2.49469072 |
| 12 | MP0002398_abnormal_bone_marrow | 2.37846983 |
| 13 | MP0006054_spinal_hemorrhage | 2.37650816 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.29507009 |
| 15 | MP0001545_abnormal_hematopoietic_system | 2.29507009 |
| 16 | MP0009785_altered_susceptibility_to | 2.24725597 |
| 17 | MP0003656_abnormal_erythrocyte_physiolo | 2.22755324 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.22148070 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.21585170 |
| 20 | MP0001819_abnormal_immune_cell | 2.18548025 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.15325451 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.14306036 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.13583286 |
| 24 | MP0002723_abnormal_immune_serum | 2.11373362 |
| 25 | MP0001790_abnormal_immune_system | 2.07804055 |
| 26 | MP0005387_immune_system_phenotype | 2.07804055 |
| 27 | MP0003787_abnormal_imprinting | 2.07261435 |
| 28 | MP0003724_increased_susceptibility_to | 2.05907490 |
| 29 | MP0000569_abnormal_digit_pigmentation | 2.05752178 |
| 30 | MP0000716_abnormal_immune_system | 1.99538422 |
| 31 | MP0005025_abnormal_response_to | 1.98166985 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.94425563 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.91424743 |
| 34 | MP0003436_decreased_susceptibility_to | 1.89244500 |
| 35 | MP0002722_abnormal_immune_system | 1.86599706 |
| 36 | MP0004147_increased_porphyrin_level | 1.82559743 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.80067816 |
| 38 | MP0002429_abnormal_blood_cell | 1.78440126 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.77235464 |
| 40 | MP0001873_stomach_inflammation | 1.76229507 |
| 41 | MP0002419_abnormal_innate_immunity | 1.75773455 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.70817571 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.70532125 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.65575730 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.64566718 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.60559093 |
| 47 | MP0002405_respiratory_system_inflammati | 1.59035446 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.56487934 |
| 49 | MP0001853_heart_inflammation | 1.52677195 |
| 50 | MP0003866_abnormal_defecation | 1.51810386 |
| 51 | MP0003828_pulmonary_edema | 1.50131550 |
| 52 | MP0004947_skin_inflammation | 1.49553099 |
| 53 | MP0004484_altered_response_of | 1.46024245 |
| 54 | MP0002095_abnormal_skin_pigmentation | 1.41823623 |
| 55 | MP0003693_abnormal_embryo_hatching | 1.40335390 |
| 56 | MP0000490_abnormal_crypts_of | 1.39945175 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.35690211 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.35508875 |
| 59 | MP0000749_muscle_degeneration | 1.34154785 |
| 60 | MP0003303_peritoneal_inflammation | 1.33373720 |
| 61 | MP0002102_abnormal_ear_morphology | 1.32470329 |
| 62 | MP0005310_abnormal_salivary_gland | 1.22529921 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.21148777 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.20442407 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.18920832 |
| 66 | MP0000372_irregular_coat_pigmentation | 1.18897349 |
| 67 | MP0002933_joint_inflammation | 1.18265326 |
| 68 | MP0000858_altered_metastatic_potential | 1.17982672 |
| 69 | MP0002009_preneoplasia | 1.15844594 |
| 70 | MP0001851_eye_inflammation | 1.12556347 |
| 71 | MP0003279_aneurysm | 1.12522082 |
| 72 | MP0008469_abnormal_protein_level | 1.10883303 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.10366414 |
| 74 | MP0010094_abnormal_chromosome_stability | 1.09027019 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 1.03075840 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.02522518 |
| 77 | MP0009278_abnormal_bone_marrow | 1.02311920 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.99869425 |
| 79 | MP0002928_abnormal_bile_duct | 0.99278852 |
| 80 | MP0008877_abnormal_DNA_methylation | 0.97715018 |
| 81 | MP0009697_abnormal_copulation | 0.94480963 |
| 82 | MP0003123_paternal_imprinting | 0.93375111 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.92535528 |
| 84 | MP0006082_CNS_inflammation | 0.89525636 |
| 85 | MP0008058_abnormal_DNA_repair | 0.87919702 |
| 86 | MP0000343_altered_response_to | 0.86650564 |
| 87 | MP0001501_abnormal_sleep_pattern | 0.86555746 |
| 88 | MP0000371_diluted_coat_color | 0.84911844 |
| 89 | MP0004957_abnormal_blastocyst_morpholog | 0.83166515 |
| 90 | MP0008872_abnormal_physiological_respon | 0.82590905 |
| 91 | MP0003786_premature_aging | 0.81391094 |
| 92 | MP0008260_abnormal_autophagy | 0.80799561 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.80335596 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.79997626 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.78878011 |
| 96 | MP0003880_abnormal_central_pattern | 0.77738039 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.77513717 |
| 98 | MP0010307_abnormal_tumor_latency | 0.77494586 |
| 99 | MP0005535_abnormal_body_temperature | 0.77158819 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.76855237 |
| 101 | MP0003943_abnormal_hepatobiliary_system | 0.75870714 |
| 102 | MP0005646_abnormal_pituitary_gland | 0.74998215 |
| 103 | MP0004381_abnormal_hair_follicle | 0.74747594 |
| 104 | MP0008995_early_reproductive_senescence | 0.74451086 |
| 105 | MP0001663_abnormal_digestive_system | 0.73058501 |
| 106 | MP0001919_abnormal_reproductive_system | 0.72760343 |
| 107 | MP0004130_abnormal_muscle_cell | 0.70923716 |
| 108 | MP0006035_abnormal_mitochondrial_morpho | 0.69252957 |
| 109 | MP0009764_decreased_sensitivity_to | 0.68548906 |
| 110 | MP0003186_abnormal_redox_activity | 0.66916119 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 0.65212643 |
| 112 | MP0009763_increased_sensitivity_to | 0.64281591 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.63530315 |
| 114 | MP0002837_dystrophic_cardiac_calcinosis | 0.63190811 |
| 115 | MP0004883_abnormal_blood_vessel | 0.62412255 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.61629174 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.61443489 |
| 118 | MP0005166_decreased_susceptibility_to | 0.61011041 |
| 119 | MP0003448_altered_tumor_morphology | 0.60982398 |
| 120 | MP0003075_altered_response_to | 0.60801750 |
| 121 | MP0003077_abnormal_cell_cycle | 0.60052321 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.59364838 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.59172222 |
| 124 | MP0000249_abnormal_blood_vessel | 0.59034188 |
| 125 | MP0003252_abnormal_bile_duct | 0.57998713 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.57121059 |
| 127 | MP0006292_abnormal_olfactory_placode | 0.57098518 |
| 128 | MP0002138_abnormal_hepatobiliary_system | 0.53854013 |
| 129 | MP0000598_abnormal_liver_morphology | 0.53638436 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.52917436 |
| 131 | MP0000313_abnormal_cell_death | 0.52832369 |
| 132 | MP0008873_increased_physiological_sensi | 0.51826011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 4.31917193 |
| 2 | Stomatitis (HP:0010280) | 4.31272178 |
| 3 | T lymphocytopenia (HP:0005403) | 4.21171752 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.08498939 |
| 5 | Recurrent bronchitis (HP:0002837) | 3.99700363 |
| 6 | IgM deficiency (HP:0002850) | 3.90502724 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.90484466 |
| 8 | Recurrent viral infections (HP:0004429) | 3.81847376 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.78838534 |
| 10 | Abnormality of T cells (HP:0002843) | 3.62481198 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.62334054 |
| 12 | Nasal polyposis (HP:0100582) | 3.61289401 |
| 13 | Thrombocytosis (HP:0001894) | 3.47583793 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 3.43218855 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43213211 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.37674117 |
| 17 | Myositis (HP:0100614) | 3.33275968 |
| 18 | Thyroiditis (HP:0100646) | 3.27611914 |
| 19 | Abnormality of B cell number (HP:0010975) | 3.26629864 |
| 20 | B lymphocytopenia (HP:0010976) | 3.26629864 |
| 21 | Petechiae (HP:0000967) | 3.26386998 |
| 22 | Decreased central vision (HP:0007663) | 3.24982155 |
| 23 | Limb-girdle muscle atrophy (HP:0003797) | 3.23318695 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.13825022 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.13139082 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.10062697 |
| 27 | Hypochromic microcytic anemia (HP:0004840) | 2.96523911 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.95079199 |
| 29 | Aplastic anemia (HP:0001915) | 2.93503993 |
| 30 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.88271181 |
| 31 | Abnormality of the prostate (HP:0008775) | 2.86539956 |
| 32 | Meningitis (HP:0001287) | 2.85887652 |
| 33 | Metaphyseal dysplasia (HP:0100255) | 2.85228133 |
| 34 | Chronic sinusitis (HP:0011109) | 2.84955041 |
| 35 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.84732578 |
| 36 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.84732578 |
| 37 | Combined immunodeficiency (HP:0005387) | 2.77677737 |
| 38 | Bronchitis (HP:0012387) | 2.76364189 |
| 39 | Periodontitis (HP:0000704) | 2.74486320 |
| 40 | Hypoplasia of the thymus (HP:0000778) | 2.73717878 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.72889537 |
| 42 | Abnormal number of erythroid precursors (HP:0012131) | 2.72299316 |
| 43 | Focal motor seizures (HP:0011153) | 2.72159474 |
| 44 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.71814098 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.71759411 |
| 46 | Verrucae (HP:0200043) | 2.66965969 |
| 47 | Papilloma (HP:0012740) | 2.66965969 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.66354549 |
| 49 | Cellulitis (HP:0100658) | 2.65066021 |
| 50 | Granulocytopenia (HP:0001913) | 2.61171097 |
| 51 | Renal cortical cysts (HP:0000803) | 2.60213751 |
| 52 | Eosinophilia (HP:0001880) | 2.59764467 |
| 53 | Encephalitis (HP:0002383) | 2.58354227 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.57719250 |
| 55 | Epistaxis (HP:0000421) | 2.57526559 |
| 56 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.57203622 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.57042464 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.56630337 |
| 59 | IgG deficiency (HP:0004315) | 2.56534034 |
| 60 | Papilledema (HP:0001085) | 2.53952156 |
| 61 | Stomach cancer (HP:0012126) | 2.52987382 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.52722732 |
| 63 | Acute hepatic failure (HP:0006554) | 2.51827496 |
| 64 | Impaired platelet aggregation (HP:0003540) | 2.49798466 |
| 65 | Abnormal platelet function (HP:0011869) | 2.49798466 |
| 66 | Dyschromatopsia (HP:0007641) | 2.46494159 |
| 67 | Lymphopenia (HP:0001888) | 2.44861837 |
| 68 | Recurrent skin infections (HP:0001581) | 2.42885782 |
| 69 | Hematochezia (HP:0002573) | 2.39966811 |
| 70 | Acute myeloid leukemia (HP:0004808) | 2.38882552 |
| 71 | Chest pain (HP:0100749) | 2.38356173 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.36090398 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35480793 |
| 74 | Abnormality of the fingertips (HP:0001211) | 2.34063346 |
| 75 | Leukocytosis (HP:0001974) | 2.30899702 |
| 76 | Visual hallucinations (HP:0002367) | 2.30838235 |
| 77 | Gingival bleeding (HP:0000225) | 2.30217140 |
| 78 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.29945472 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.28290037 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.26070463 |
| 81 | Febrile seizures (HP:0002373) | 2.25841656 |
| 82 | Microcytic anemia (HP:0001935) | 2.24496474 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.22132441 |
| 84 | Vasculitis (HP:0002633) | 2.21935740 |
| 85 | Alveolar cell carcinoma (HP:0006519) | 2.21535835 |
| 86 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18272933 |
| 87 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.18020593 |
| 88 | Lymphoma (HP:0002665) | 2.14701349 |
| 89 | Albinism (HP:0001022) | 2.13337731 |
| 90 | Abnormal platelet volume (HP:0011876) | 2.12844996 |
| 91 | Abnormality of the renal cortex (HP:0011035) | 2.12189422 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 2.12101662 |
| 93 | Papillary thyroid carcinoma (HP:0002895) | 2.11426504 |
| 94 | Colitis (HP:0002583) | 2.08562777 |
| 95 | Cone-rod dystrophy (HP:0000548) | 2.05176827 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.04393642 |
| 97 | IgA deficiency (HP:0002720) | 2.02905850 |
| 98 | Recurrent sinusitis (HP:0011108) | 2.02511036 |
| 99 | Pustule (HP:0200039) | 2.01982522 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01925976 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01925976 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 1.99920293 |
| 103 | Osteomyelitis (HP:0002754) | 1.99180965 |
| 104 | Neurodegeneration (HP:0002180) | 1.97638626 |
| 105 | Orchitis (HP:0100796) | 1.97411687 |
| 106 | Absent frontal sinuses (HP:0002688) | 1.96855463 |
| 107 | Thyroid carcinoma (HP:0002890) | 1.96524015 |
| 108 | 3-Methylglutaconic aciduria (HP:0003535) | 1.95627446 |
| 109 | Increased IgE level (HP:0003212) | 1.94697358 |
| 110 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94665514 |
| 111 | Volvulus (HP:0002580) | 1.93810201 |
| 112 | Myelodysplasia (HP:0002863) | 1.91196558 |
| 113 | Keratoconjunctivitis sicca (HP:0001097) | 1.89879258 |
| 114 | Acanthocytosis (HP:0001927) | 1.89420536 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 1.88164079 |
| 116 | Optic neuritis (HP:0100653) | 1.88164079 |
| 117 | Acute lymphatic leukemia (HP:0006721) | 1.87621527 |
| 118 | Pulmonary embolism (HP:0002204) | 1.85562289 |
| 119 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.85391773 |
| 120 | Atonic seizures (HP:0010819) | 1.84732951 |
| 121 | Joint swelling (HP:0001386) | 1.84551641 |
| 122 | Vertigo (HP:0002321) | 1.83768942 |
| 123 | 11 pairs of ribs (HP:0000878) | 1.83172839 |
| 124 | Autoimmune thrombocytopenia (HP:0001973) | 1.82121936 |
| 125 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82084701 |
| 126 | Abnormality of lateral ventricle (HP:0030047) | 1.81498518 |
| 127 | Constricted visual fields (HP:0001133) | 1.81106892 |
| 128 | Erythema (HP:0010783) | 1.80387259 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.79701071 |
| 130 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.78843729 |
| 131 | Subaortic stenosis (HP:0001682) | 1.78843729 |
| 132 | Poikilocytosis (HP:0004447) | 1.78540629 |
| 133 | Exertional dyspnea (HP:0002875) | 1.78441083 |
| 134 | Hemoptysis (HP:0002105) | 1.77315290 |
| 135 | Arterial thrombosis (HP:0004420) | 1.76165758 |
| 136 | Fatigue (HP:0012378) | 1.75709665 |
| 137 | Neutropenia (HP:0001875) | 1.75705402 |
| 138 | Chronic diarrhea (HP:0002028) | 1.75539423 |
| 139 | Skin ulcer (HP:0200042) | 1.74807431 |
| 140 | Hypochromic anemia (HP:0001931) | 1.72864089 |
| 141 | Obstructive lung disease (HP:0006536) | 1.70912223 |
| 142 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70912223 |
| 143 | Bronchiectasis (HP:0002110) | 1.69647045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.01656522 |
| 2 | TXK | 2.92152654 |
| 3 | STK16 | 2.81667543 |
| 4 | CAMKK2 | 2.75248568 |
| 5 | BRSK2 | 2.64929570 |
| 6 | BMPR2 | 2.40484007 |
| 7 | TEC | 2.37720886 |
| 8 | MAP4K2 | 2.32424950 |
| 9 | ZAP70 | 2.31513730 |
| 10 | RIPK4 | 2.21532461 |
| 11 | BTK | 2.16859382 |
| 12 | NUAK1 | 1.95176023 |
| 13 | MAP3K12 | 1.93703437 |
| 14 | SYK | 1.88369623 |
| 15 | SCYL2 | 1.87180734 |
| 16 | FLT3 | 1.84502400 |
| 17 | KIT | 1.84189876 |
| 18 | TAOK3 | 1.82547573 |
| 19 | MST4 | 1.81465071 |
| 20 | NME2 | 1.79096928 |
| 21 | JAK3 | 1.74620112 |
| 22 | ITK | 1.65798418 |
| 23 | GRK6 | 1.64299334 |
| 24 | MAP3K13 | 1.63254652 |
| 25 | EEF2K | 1.54318822 |
| 26 | TBK1 | 1.53365690 |
| 27 | JAK1 | 1.50016722 |
| 28 | TYK2 | 1.47748509 |
| 29 | CCNB1 | 1.46181767 |
| 30 | BUB1 | 1.44788351 |
| 31 | IKBKE | 1.44656587 |
| 32 | STK10 | 1.42383382 |
| 33 | LRRK2 | 1.38451862 |
| 34 | ACVR1B | 1.37917689 |
| 35 | ERN1 | 1.37294738 |
| 36 | BRSK1 | 1.35283190 |
| 37 | PLK2 | 1.34191322 |
| 38 | RPS6KA4 | 1.27483290 |
| 39 | TRIB3 | 1.22630752 |
| 40 | PKN2 | 1.18882136 |
| 41 | CDC7 | 1.15848416 |
| 42 | CSF1R | 1.15274755 |
| 43 | IRAK4 | 1.15135888 |
| 44 | MAP2K3 | 1.13120659 |
| 45 | ERBB3 | 1.11113091 |
| 46 | FES | 1.10959180 |
| 47 | TNK2 | 1.10536255 |
| 48 | CDK4 | 1.10414075 |
| 49 | MKNK1 | 1.10060317 |
| 50 | EIF2AK1 | 1.05755585 |
| 51 | PDK1 | 0.99893763 |
| 52 | BLK | 0.99793264 |
| 53 | PBK | 0.99474456 |
| 54 | TAF1 | 0.99152025 |
| 55 | BCKDK | 0.98313772 |
| 56 | DAPK1 | 0.95115324 |
| 57 | LCK | 0.94495828 |
| 58 | MAP2K6 | 0.92950112 |
| 59 | CAMKK1 | 0.90387418 |
| 60 | TGFBR2 | 0.89002418 |
| 61 | LYN | 0.87493436 |
| 62 | HCK | 0.87412411 |
| 63 | MATK | 0.87373424 |
| 64 | RAF1 | 0.87194284 |
| 65 | IKBKB | 0.86547333 |
| 66 | EIF2AK3 | 0.86243177 |
| 67 | MAP3K14 | 0.85821670 |
| 68 | GRK5 | 0.83777007 |
| 69 | PIM1 | 0.83587113 |
| 70 | NLK | 0.83555078 |
| 71 | PIM2 | 0.81325129 |
| 72 | MAPKAPK3 | 0.81188551 |
| 73 | CLK1 | 0.80980049 |
| 74 | DAPK2 | 0.80479830 |
| 75 | PINK1 | 0.79673471 |
| 76 | STK4 | 0.79254599 |
| 77 | BMPR1B | 0.77549941 |
| 78 | CSK | 0.77159975 |
| 79 | JAK2 | 0.76294129 |
| 80 | NEK2 | 0.75257863 |
| 81 | MAPK11 | 0.75164550 |
| 82 | FGFR3 | 0.74967743 |
| 83 | EIF2AK2 | 0.74910901 |
| 84 | OXSR1 | 0.73345804 |
| 85 | KDR | 0.72638943 |
| 86 | NEK9 | 0.71777047 |
| 87 | IRAK1 | 0.68944572 |
| 88 | MAP3K10 | 0.68737482 |
| 89 | MUSK | 0.67947656 |
| 90 | MAP3K8 | 0.67652877 |
| 91 | VRK1 | 0.67644550 |
| 92 | CDK6 | 0.67605880 |
| 93 | PTK2B | 0.67547191 |
| 94 | AKT3 | 0.66511163 |
| 95 | MARK3 | 0.64524777 |
| 96 | MAPK4 | 0.63840273 |
| 97 | HIPK2 | 0.62552220 |
| 98 | PLK3 | 0.62380064 |
| 99 | CDK9 | 0.61418308 |
| 100 | MAP3K6 | 0.60272420 |
| 101 | MKNK2 | 0.59919570 |
| 102 | PRKCQ | 0.59741575 |
| 103 | MAPK7 | 0.58254864 |
| 104 | STK24 | 0.57357835 |
| 105 | FRK | 0.57239459 |
| 106 | ZAK | 0.55959302 |
| 107 | PRKG2 | 0.55100577 |
| 108 | ATR | 0.54677655 |
| 109 | PDPK1 | 0.54665834 |
| 110 | TAOK2 | 0.54559470 |
| 111 | SGK2 | 0.53821496 |
| 112 | MYLK | 0.50478111 |
| 113 | PDK3 | 0.50208180 |
| 114 | PDK4 | 0.50208180 |
| 115 | TRPM7 | 0.49229849 |
| 116 | TGFBR1 | 0.46803097 |
| 117 | FGR | 0.46734901 |
| 118 | ADRBK2 | 0.45298327 |
| 119 | BRD4 | 0.45241018 |
| 120 | STK3 | 0.44296450 |
| 121 | MAP3K4 | 0.43637639 |
| 122 | MAP3K3 | 0.43230166 |
| 123 | DYRK1A | 0.42706831 |
| 124 | MAP3K11 | 0.42091770 |
| 125 | RPS6KB2 | 0.42035610 |
| 126 | CDK19 | 0.41256916 |
| 127 | MAP3K1 | 0.40690625 |
| 128 | FGFR2 | 0.40398804 |
| 129 | MAP3K5 | 0.40385466 |
| 130 | ABL1 | 0.40257639 |
| 131 | PIK3CG | 0.39315007 |
| 132 | CDK7 | 0.39186650 |
| 133 | MINK1 | 0.38875904 |
| 134 | MAPKAPK5 | 0.37878844 |
| 135 | TNIK | 0.37515042 |
| 136 | RPS6KB1 | 0.37355204 |
| 137 | YES1 | 0.36728248 |
| 138 | FER | 0.35555563 |
| 139 | PASK | 0.35222520 |
| 140 | PRKCH | 0.34647822 |
| 141 | MAP2K4 | 0.34588754 |
| 142 | STK39 | 0.34305464 |
| 143 | MAP3K7 | 0.33488308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.16217037 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.85808219 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.74246527 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.67588978 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.46035828 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39509150 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.18654987 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15409393 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.03545108 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 1.99225282 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.90342999 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.87657171 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84686531 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77243455 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63204035 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61376313 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60539510 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.59172781 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53626942 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52654411 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.51080264 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50604510 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.47607093 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.46750543 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45604021 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45125054 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42857297 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42497631 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.42144613 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40155459 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.39852616 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.36084700 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31993758 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.28468843 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.27320149 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24213963 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21531867 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21040628 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20902745 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19725591 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.18818566 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18036561 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17639607 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.12945827 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12729988 |
| 46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.11791617 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10891417 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.09077818 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08908078 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08859958 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.08592176 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 1.03915841 |
| 53 | Cell cycle_Homo sapiens_hsa04110 | 1.03671482 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03366604 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.03256971 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01375903 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00683716 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99208095 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98206341 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96548270 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96022521 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95470331 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93656021 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92821170 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.92078919 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.89506558 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.88843930 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.88818920 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88688672 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.88372001 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87637263 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87022576 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79681517 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.78628934 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76274694 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76272126 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76243774 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75513409 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74735072 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72505624 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72197635 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71193668 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70347867 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.69635781 |
| 85 | Spliceosome_Homo sapiens_hsa03040 | 0.68430779 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67819929 |
| 87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66761129 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66704425 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65816291 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65483544 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64479118 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63407497 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63119870 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62456551 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61492828 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60982499 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59987584 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59250602 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58438454 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57674018 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.55572886 |
| 102 | Proteasome_Homo sapiens_hsa03050 | 0.55566325 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54646191 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54389003 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54265527 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.53338795 |
| 107 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53021950 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51924022 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51902744 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51880250 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50954252 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50525299 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49975299 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49838090 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.49471576 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.47929135 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46059601 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45040938 |
| 119 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44476518 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44090245 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44060018 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43343886 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43103860 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42936127 |
| 125 | RNA transport_Homo sapiens_hsa03013 | 0.42825957 |
| 126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42653514 |
| 127 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41732142 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41006511 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40177011 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39546013 |
| 131 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38861497 |
| 132 | Malaria_Homo sapiens_hsa05144 | 0.38787416 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38621110 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38542328 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38443196 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.37845421 |
| 137 | Morphine addiction_Homo sapiens_hsa05032 | 0.37733080 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37445809 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36103540 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.35274608 |

